Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OncoSil MedicalASX:OSL -1.79%48 Days Payable is 332.38 as of Dec. 2025, which is 45% above its 10-year median of 228.65. GuruFocus rates ASX:OSL with a GF Score™ of 48/100 and a GF Value™ of A$2.90 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, OncoSil Medical ranks better than 90.7% on this metric.
The historical rank and industry rank for OncoSil Medical's Days Payable or its related term are showing as below:
ASX:OSL'
s Days Payable Range Over the Past 10 Years
Min: 217.19 Med: 228.65 Max: 490.53
Current: 357.66
During the past 13 years, OncoSil Medical's highest Days Payable was 490.53. The lowest was 217.19. And the median was 228.65.
ASX:OSL's Days Payable is ranked better than 90.7% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ASX:OSL: 357.66
OncoSil Medical's Days Payable
declined
from Dec. 2024 (339.80) to Dec. 2025 (332.38).
It may suggest that OncoSil Medicalaccelerated paying its suppliers.
OncoSil Medical Days Payable Related Terms
OncoSil Medical Days Payable Historical Data
* Premium members only.
The historical data trend for OncoSil Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, OncoSil Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OncoSil Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OncoSil Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where OncoSil Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
OncoSil Medical's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OncoSil Medical (ASX:OSL) has a Days Payable of 332.38 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OncoSil Medical and its competitors. This is 45% above median its historical median of 228.65. Over the past decade, OncoSil Medical's Days Payable has ranged from 217.19 to 490.53. According to the industry distribution chart, OncoSil Medical ranks #74 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 9.3%.
Is OncoSil Medical's Days Payable too high?
OncoSil Medical's current Days Payable of 332.38 is 45% above median its 10-year median of 228.65. Over the past 10 years, this metric has ranged from a low of 217.19 to a high of 490.53. The Medical Devices & Instruments industry median Days Payable is 67.97. OncoSil Medical's value of 332.38 is 389% above this industry median. Based on the distribution chart, OncoSil Medical ranks #74 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OncoSil Medical has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OncoSil Medical's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OncoSil Medical ranks #74 out of 796 companies for Days Payable. This places OncoSil Medical in the top 9% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.97. OncoSil Medical's value of 332.38 is 389% above this benchmark. Historically, OncoSil Medical's own Days Payable has ranged from 217.19 to 490.53 over the past decade. While the company's 10-year median is 228.65 vs. the industry median of 67.97, OncoSil Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OncoSil Medical's current Days Payable of 332.38 is 389% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OncoSil Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OncoSil Medical's current Days Payable is 332.38, which is 45% above median its own 10-year median of 228.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSil Medical stock overvalued right now?
Based on GuruFocus' analysis, OncoSil Medical (ASX:OSL) is currently considered Possible Value Trap. The stock's GF Value™ is A$2.90, compared to a current price of A$1.38 — trading 52.6% below its estimated fair value. The current Days Payable is 332.38, which is 45% above median its 10-year median of 228.65 and 389% above the Medical Devices & Instruments industry median of 67.97. OncoSil Medical's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For OncoSil Medical (ASX:OSL), the current Days Payable is 332.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OncoSil Medical (ASX:OSL) Overvalued in 2026?
Based on GuruFocus' analysis, OncoSil Medical stock appears to be undervalued.
The current stock price of A$1.38 is trading 52.6% below its estimated GF Value™ of A$2.90.
GuruFocus considers OncoSil Medical to be Possible Value Trap.
Key valuation signals for ASX:OSL:
Days Payable: 332.38 (45% above median its 10-year median of 228.65)
GF Value™: A$2.90 vs. price of A$1.38 (52.6% below fair value)
Industry Position: 389% above the Medical Devices & Instruments median (#74 of 796)
No single metric tells the full story. See the ASX:OSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.
48GF Score
Get the complete analysis for ASX:OSL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:OSL has been successfully added to your 
